Shared on 03 Nov 25
Fair value Increased 0.61%Analysts have modestly raised their price targets for WSP Global, with the fair value estimate increasing from C$318.21 to C$320.14. They cite continued positive revenue growth expectations and recent upward revisions by major research firms.
Shared on 20 Oct 25
Fair value Increased 1.64%WSP Global’s fair value estimate has been increased by nearly $5 to $318.21. Analysts factored in recent upward adjustments to price targets, reflecting improved revenue forecasts and sustained confidence in the company’s outlook.
Shared on 04 Sep 25
With no change in the consensus analyst price target (CA$313.07) and both the discount rate and revenue growth forecasts remaining stable, analysts see limited shifts in WSP Global’s valuation outlook. What's in the News WSP Global continues to actively pursue M&A, highlighted by the acquisition of Lexica, a U.K.-based consulting firm specializing in healthcare and life sciences, strengthening its advisory capabilities in the region.
Shared on 23 Apr 25
Fair value Decreased 0.49%AnalystConsensusTarget has increased revenue growth from -0.3% to -0.2%.
Shared on 17 Apr 25
Fair value Decreased 0.12%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 4.96%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Decreased 1.90%AnalystConsensusTarget has decreased revenue growth from 0.0% to -0.3% and increased future PE multiple from 33.7x to 37.7x.

